Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00862862 · ClinicalTrials.gov registry record
Evaluation of Vancomycin Treatment of Infections Due to Staphylococcus Aureus
A clinical trial, sponsored by University of Nebraska.
- Terminated
- Registry status
- 250
- Enrollment target
NCT00862862 is a clinical trial that was terminated before completion, run by University of Nebraska. The registered enrollment target is 250 participants.
The verdict
NCT00862862 was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- 250 participants
- Enrollment target
Study Summary
Objective: The objective of the study is to evaluate the ability of current vancomycin dosing strategies to attain the pharmacodynamic target of an area under the curve (AUC) to minimum inhibitory concentration (MIC) ratio greater than 400:1 for patients with a suspected or documented Staphylococcus aureus infection. Primary Outcome: The primary outcome is the percentage of vancomycin dosing regimens that achieve AUC:MIC ratio \> 400 on the first occurrence of vancomycin use in patients with a suspected or documented S. aureus infection at The Nebraska Medical Center. Secondary Outcomes: 1. To assess the probability that vancomycin AUC:MIC ratios obtained from The Nebraska Medical Center patients exceed a therapeutic threshold using S. aureus MICs from isolates obtained from The Nebraska Medical Center. 2. Using MIC data from the TRUST Study database (large national surveillance database) and the vancomycin AUC data obtained from TNMC patients, perform a Monte Carlo analysis that will assess the probability of achieving a therapeutic vancomycin threshold with a large number of isolates.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2009-04-01 |
| Est. Completion | 2011-02-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00862862
The ClinicalTrials.gov registry entry for NCT00862862 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00862862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00862862 about?
NCT00862862 is a clinical study titled "Evaluation of Vancomycin Treatment of Infections Due to Staphylococcus Aureus". Objective: The objective of the study is to evaluate the ability of current vancomycin dosing strategies to attain the pharmacodynamic target of an area under the curve (AUC) to minimum inhibitory concentration (MIC) ratio greater than 400:1 for patients with a suspected or documented Staphylococcus...
What is the current status of trial NCT00862862?
This trial is currently terminated. The enrollment target is 250 participants. The study started on 2009-04-01. Estimated completion is 2011-02-03.
Who is sponsoring clinical trial NCT00862862?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.